127 related articles for article (PubMed ID: 28238063)
1. Functional germline variants in driver genes of breast cancer.
Göhler S; Da Silva Filho MI; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
Cancer Causes Control; 2017 Apr; 28(4):259-271. PubMed ID: 28238063
[TBL] [Abstract][Full Text] [Related]
2. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
3. Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population.
Göhler S; Da Silva Filho MI; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
J Cancer Res Clin Oncol; 2016 Jan; 142(1):273-6. PubMed ID: 26320772
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.
Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
Breast Cancer Res Treat; 2011 Aug; 129(1):235-45. PubMed ID: 21455670
[TBL] [Abstract][Full Text] [Related]
5. Association of Germline Variation in Driver Genes with Breast Cancer Risk in Chilean Population.
Morales-Pison S; Tapia JC; Morales-González S; Maldonado E; Acuña M; Calaf GM; Jara L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003265
[TBL] [Abstract][Full Text] [Related]
6. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
7. Germline Variants in Driver Genes of Breast Cancer and Their Association with Familial and Early-Onset Breast Cancer Risk in a Chilean Population.
Fernandez-Moya A; Morales S; Arancibia T; Gonzalez-Hormazabal P; Tapia JC; Godoy-Herrera R; Reyes JM; Gomez F; Waugh E; Jara L
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31968594
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
[TBL] [Abstract][Full Text] [Related]
9. The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer.
Toomey S; Madden SF; Furney SJ; Fan Y; McCormack M; Stapleton C; Cremona M; Cavalleri GL; Milewska M; Elster N; Carr A; Fay J; Kay EW; Kennedy S; Crown J; Gallagher WM; Hennessy BT; Eustace AJ
Oncotarget; 2016 Nov; 7(46):75518-75525. PubMed ID: 27776352
[TBL] [Abstract][Full Text] [Related]
10. A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.
Bensen JT; Graff M; Young KL; Sethupathy P; Parker J; Pecot CV; Currin K; Haddad SA; Ruiz-Narváez EA; Haiman CA; Hong CC; Sucheston-Campbell LE; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Lunetta KL; Ambrosone CB; Palmer JR; Troester MA; Olshan AF
Breast Cancer Res; 2018 Jun; 20(1):45. PubMed ID: 29871690
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer.
Lee SE; Lee HS; Kim KY; Park JH; Roh H; Park HY; Kim WS
Sci Rep; 2019 Jul; 9(1):10966. PubMed ID: 31358837
[TBL] [Abstract][Full Text] [Related]
12. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
Kim KY; Han W; Noh DY; Kang D; Kwack K
Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
[TBL] [Abstract][Full Text] [Related]
13. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.
Brendle A; Brandt A; Johansson R; Enquist K; Hallmans G; Hemminki K; Lenner P; Försti A
Eur J Cancer; 2009 Feb; 45(3):435-42. PubMed ID: 19008095
[TBL] [Abstract][Full Text] [Related]
16. Sequencing for germline mutations in Swedish breast cancer families reveals novel breast cancer risk genes.
Helgadottir HT; Thutkawkorapin J; Lagerstedt-Robinson K; Lindblom A
Sci Rep; 2021 Jul; 11(1):14737. PubMed ID: 34282249
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer.
Shi H; Bevier M; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
Breast Cancer Res Treat; 2012 Feb; 131(3):1039-47. PubMed ID: 22037783
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.
Huhn S; Bevier M; Pardini B; Naccarati A; Vodickova L; Novotny J; Vodicka P; Hemminki K; Försti A
Cancer Causes Control; 2014 Jun; 25(6):759-69. PubMed ID: 24706189
[TBL] [Abstract][Full Text] [Related]
19. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
[TBL] [Abstract][Full Text] [Related]
20. Inherited variants in genes somatically mutated in thyroid cancer.
Campo C; Köhler A; Figlioli G; Elisei R; Romei C; Cipollini M; Bambi F; Hemminki K; Gemignani F; Landi S; Försti A
PLoS One; 2017; 12(4):e0174995. PubMed ID: 28410400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
